The use of biological and immunosuppressive therapy in Crohn’s disease(CD) changed favorably the course of the disease and is currently suggested in the preven
Inflammatory bowel disease(IBD) patients exhibit higher risk for bone loss than the general population. The chronic inflammation causes a reduction in bone mine